Biotech Startups

Cerecura is a biotech company focused on developing RNA therapies to treat neurological disorders and neurodegeneration. The company leverages drug delivery expertise and neuroscience research to create next-generation treatments for patients with brain diseases.

1 investor

Pharmaceutical company developing novel approach to Alzheimer's disease

1 investor

Cerevanta provides AI-powered analysis of brain imaging to help neurologists make clinical decisions more effectively. The platform targets neurology care providers to reduce diagnostic delays and improve patient outcomes.

1 investor

CereVasc is developing the eShunt System, a minimally invasive device intended to treat communicating hydrocephalus in children and adults as an alternative to invasive neurosurgical procedures. The company operates in the medical device sector for neurological conditions.

1 investor

Cergentis is now part of Solvias and provides Targeted Locus Amplification (TLA) technology and genetic characterization services for advanced therapy development. The company serves pharmaceutical and biotech innovators with CMC analytical testing from drug development through commercialization.

1 investor

1 investor

Certa Therapeutics develops targeted therapeutics to treat fibrotic diseases including scleroderma, chronic kidney disease, diabetic nephropathy, and focal segmental glomerulosclerosis. The company serves patients with serious, often life-threatening fibrotic conditions.

1 investor

CERTANIA provides testing, inspection, and certification services across areas such as food testing, pharmaceutical examination, and building inspection. It combines technical expertise with digital tools to deliver these safety and compliance services to customers.

1 investor

Certara provides biosimulation software, modeling, and regulatory services that support drug discovery and development across discovery, preclinical, clinical, regulatory, and market access phases. It serves pharmaceutical and biotech organizations seeking to make data-driven decisions and streamline regulatory submissions.

1 investor

Certified Laboratories operates a network of 30+ ISO 17025-accredited testing labs across North America, providing microbiology, analytical chemistry, contract research, and certification & audit services. It serves the food & beverage industry as well as cosmetics, personal care, over-the-counter drug, dietary supplement, and botanical companies with safety and quality testing.

1 investor

Ceryx Medical develops medical device technology, presenting a leadership and research team alongside its publications. The page provides limited detail on the specific product beyond the company's medical technology focus.

1 investor

Cumberland Emerging Technologies provides development partnerships with researchers and companies to advance early-stage biomedical technologies toward commercialization, and operates a life sciences incubator facility in Nashville offering laboratory space and support services to pharmaceutical, medical device, and diagnostics firms.

1 investor

CGenetix develops liquid biopsy biomarkers using circulating cell-free DNA to detect organ damage, with a focus on transplantation (kidney, lung, pancreas) rejection diagnostics. The company applies techniques such as digital PCR, NGS and bioinformatics to build in vitro diagnostic tests for the medical and clinical community.

1 investor

CHA Biotech is a South Korean biotechnology company operating in areas including cord blood banking, cell insurance, genomics, CDMO manufacturing, and healthcare consulting. It also runs related businesses such as the Chaum health center and IT services.

1 investor

Chainreactor builds patented modular benchtop bioreactors and accompanying software that replicate industrial-scale physics, letting biomanufacturers design, predict, and test cell behavior before scaling up production. It serves biotech and biomanufacturing companies as a "picks and shovels" hardware/software provider for scaling bioprocesses.

1 investor

1 investor

Cheiron is a pharmaceutical AI platform that synthesizes scientific literature, clinical evidence, regulatory documents, and safety data to provide verifiable insights for drug discovery, clinical development, medical affairs, and regulatory workflows in the biopharma industry.

1 investor

Chemical.AI transforms chemical synthesis through artificial intelligence and retrosynthetic analysis, serving pharmaceutical, biotech, and contract research organizations with tools to optimize synthetic routes and accelerate drug discovery.

1 investor

ChemID provides a data management platform that extracts, translates, and centralizes chemical and lab data from multiple file formats, with visualization tools and blockchain-secured storage for laboratories and chemical organizations.

1 investor

Chemon is a non-clinical contract research organization (CRO) that provides GLP-compliant efficacy and toxicity testing, quality assurance, and regulatory support for pharmaceuticals, agrochemicals, and chemicals. It serves clients seeking product approval and registration, offering custom non-clinical strategy and alternative testing services aligned with global regulatory standards.

1 investor

ChemoPharma is a solutions platform in Malaysia providing clinical diagnostics, analytical and industrial solutions for oil and gas, and life sciences offerings. The company also delivers laboratory information management systems, project management, and technical support services across the diagnostic and scientific technology value chain.

1 investor

Circadian Health develops technology solutions that optimize human health and performance through understanding and applying circadian science, with expertise in light's impact on biological rhythms.

1 investor

Chiesi is a global pharmaceutical company that develops and distributes medications across multiple therapeutic areas. The company operates through subsidiaries in Europe, Asia, the Americas, and other regions.

1 investor

Chiima Therapeutics is a biotech company developing first-in-class, non-hormonal therapies for women's health conditions with unmet needs, including endometriosis, pre-term labor, and PCOS. Its pipeline covers investigational compounds addressing diseases that affect women worldwide.

1 investor